Skip to main content
Go to the home page of the European Commission (opens in new window)
English English
CORDIS - EU research results
CORDIS

Neuronal control of fascia

Project description

Fascia innervation and organ damage control

The connective tissue fascia is the largest tissue in the body, delineating the skin and all organs. The reasons why this mechanical barrier is populated with immune cells and innervated by sensory and sympathetic neurons are unclear. The ERC-funded NEUROFASCIA project proposes that fascia forms a sensory platform for detecting damage to the tissues and communicates information to the brain to initiate corrective mechanisms and immune activity. The preliminary results indicate that chronic depression in mice or optogenetic activation of sympathetic fascia innervations induces immune changes in the fascia. The project objectives include characterisation of the fascia innervation and resident immune cells, the study of the manifestation of fascia inflammation in the brain, and understanding the neural control of the fascia and its immune state.

Objective

The fascia is the largest tissue in the body, yet most of us never heard of it. This connective tissue delineates the skin, surrounds muscles, and closely envelops all organs. Clinically, it is mainly considered a mechanical barrier separating organs and muscles. But why should a simple barrier be populated with immune cells and receive extensive innervation by sensory and sympathetic neurons?

Here we propose that the fascia generates a sensory platform that detects damage to the tissues it envelops and communicates this information to the brain which in turn, initiates corrective programs and modulates immune activity. Our preliminary results support this hypothesis indicating that chronic depression in mice and direct optogenetic activation of sympathetic fascia innervations induce immune changes in the fascia.

We propose three major aims:
A) Characterization: Identify the anatomical and genetic characteristics of fascia innervation and fascia resident immune cells
B) Function: Determine how fascia inflammation is represented in the brain and how it affects pain responses
C) Modulation: Demonstrate how neural control of the fascia affects this tissue and its immune state

My multidisciplinary background uniquely positions me to study this novel aspect of brain-body communication. We will use viral tracing and spatial transcriptomics to characterize the fascia’s innervation; optogenetics to locally control neurons in the fascia; chemogenetics to manipulate brain activity; and high-dimensional immune characterization to establish the immunological outcomes in the fascia.

NEUROFASCIA has the potential to transform our understanding of brain-immune communication and open new therapeutic avenues for disease such as myofascial pain syndrome, endometriosis, and fibromyalgia, which are accompanied by low-grade inflammation and altered fascia innervation.

Keywords

Project’s keywords as indicated by the project coordinator. Not to be confused with the EuroSciVoc taxonomy (Fields of science)

Programme(s)

Multi-annual funding programmes that define the EU’s priorities for research and innovation.

Topic(s)

Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.

Funding Scheme

Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.

HORIZON-ERC - HORIZON ERC Grants

See all projects funded under this funding scheme

Call for proposal

Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.

(opens in new window) ERC-2022-COG

See all projects funded under this call

Host institution

TEL AVIV UNIVERSITY
Net EU contribution

Net EU financial contribution. The sum of money that the participant receives, deducted by the EU contribution to its linked third party. It considers the distribution of the EU financial contribution between direct beneficiaries of the project and other types of participants, like third-party participants.

€ 1 897 200,00
Total cost

The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.

€ 1 897 200,00

Beneficiaries (1)

My booklet 0 0